Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Irish Journal of Medical Science (1971 -)
Published in: Irish Journal of Medical Science (1971 -) 1/2011

01-03-2011 | Brief Report

Anti-glycolipid GM2-positive Guillain–Barre syndrome due to hepatitis E infection

Authors: S. Cronin, R. McNicholas, E. Kavanagh, V. Reid, K. O’Rourke

Published in: Irish Journal of Medical Science (1971 -) | Issue 1/2011

Login to get access

Abstract

Background

Hepatitis E infection is most prevalent in developing countries with poor sanitation, but can also occur apparently sporadically in more developed areas.

Case

We here report a second European case of Guillain–Barre syndrome due to hepatitis E infection in association with anti-glycolipid GM2 antibody.

Interpretation

This is likely to be a specific association involving molecular mimicry, and further European cases can therefore be expected.
Literature
1.
Aggarwal R, Naik S (2009) Epidemiology of hepatitis E: current status. J Gastroenterol Hepatol 24:1484–1493CrossRefPubMed
2.
Loly JP, Rikir E, Seivert M et al (2009) Guillain–Barre syndrome following hepatitis E. World J Gastroenterol 15:1645–1647CrossRefPubMed
3.
Sood A, Midha V, Sood N (2000) Guillain–Barre syndrome with acute hepatitis E. Am J Gastroenterol 95:3667–3668PubMed
4.
Kamani P, Baijal R, Amarapurkar D et al (2005) Guillain–Barre syndrome associated with acute hepatitis E. Indian J Gastroenterol 24:216PubMed
5.
Kumar R, Bhoi S, Kumar M et al (2002) Guillain–Barre syndrome and acute hepatitis E: a rare association. J Indian Acad Clin Med 3:389–391
6.
Ono S, Chida K, Takasu T (1994) Guillain–Barre syndrome following fulminant viral hepatitis A. Intern Med 33:799–801CrossRefPubMed
7.
Tsukada N, Koh C, Inoue A et al (1987) Demyelinating neuropathy associated with hepatitis B virus infection. J Neurol Sci 77:203–216CrossRefPubMed
8.
Klippel N, Hautekeete M, Keyser J et al (1993) Guillain–Barre syndrome as the presenting manifestation of hepatitis C infection. Neurology 43:2143PubMed
9.
Lin S, Ryu S, Liaw Y (1989) Guillain–Barre syndrome associated with acute delta hepatitis virus superinfection. J Med Virol 28:144–145CrossRefPubMed
10.
Yadav K, Rohatgi A, Sharma S et al (2002) Oculomotor palsy associated with hepatitis E infection. J Assoc Physicians India 50:731
11.
Kejariwal D, Roy S, Sarkar N (2001) Seizure associated with acute hepatitis E. Neurology 57:1935PubMed
12.
Mandal K, Chopra N (2006) Acute transverse myelitis following hepatitis E virus infection. Indian Pediatr 43:365–366PubMed
13.
Fong F, Illahi M (2009) Neuralgia amyotrophy associated with hepatitis E virus. Clin Neurol Neurosurg 111:193–195CrossRefPubMed
14.
Kamar N, Izopet J, Cintas P et al (2010) Hepatitis E virus-induced neurological symptoms in a kidney-transplant patient with chronic hepatitis. Am J Transplant 10:1321–1324CrossRefPubMed
15.
Dalton H, Bendall R, Ijaz S et al (2008) Hepatitis E: an emerging infection in developed countries. Lancet Infect Dis 8:698–709CrossRefPubMed
16.
17.
Carpo M, Pedotti R, Allaria S et al (1999) Clinical presentation and outcome of Guillain–Barre and related syndromes in relation to anti-ganglioside antibodies. J Neurol Sci 168:178–184CrossRef
18.
Hartnung HP, Kieseier R (1999) Antibody responses in the Guillain–Barre syndrome. J Neurol Sci 168:75–77CrossRef
19.
Sheikh K, Ho T, Nachamkin I et al (1998) Molecular mimicry in Guillain–Barre syndrome. Ann N Y Acad Sci 845:307–321CrossRefPubMed
Metadata
Title
Anti-glycolipid GM2-positive Guillain–Barre syndrome due to hepatitis E infection
Authors
S. Cronin
R. McNicholas
E. Kavanagh
V. Reid
K. O’Rourke
Publication date
01-03-2011
Publisher
Springer-Verlag
Published in
Irish Journal of Medical Science (1971 -) / Issue 1/2011
Print ISSN: 0021-1265
Electronic ISSN: 1863-4362
DOI
https://doi.org/10.1007/s11845-010-0635-7

Other articles of this Issue 1/2011

Irish Journal of Medical Science (1971 -) 1/2011 Go to the issue

Original Article

A review of 100 consecutive sutureless child and adult circumcisions

Original Article

An audit of the impact of a stroke unit in an acute teaching hospital

Original Article

Normative curves of fetal nasal bone length for the ethnic Chinese population

Original Article

Practices for predicting and preventing preterm birth in Ireland: a national survey

Case Report

Pulmonary artery leiomyosarcoma: an unusual cause of shortness of breath

Original Article

17β-Estradiol attenuates diet-induced insulin resistance and glucose intolerance through up-regulation of caveolin-3
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits